Efficacy and tolerability of sofosbuvir and daclatasvir for treatment of hepatitis C genotype 1 & 3 in patients undergoing hemodialysis- a prospective interventional clinical trial

There is paucity of data using direct anti-viral agents (DAA) in patients on maintenance hemodialysis (MHD) infected with HCV-genotype 1& 3. Aim of the study was to evaluate DAA therapy in patients infected w...

Source: BMC Nephrology - November 28, 2019 Category: Urology & Nephrology Authors: Shafiq Ur Rehman Cheema, Muhammad Salman Rehman, Ghulam Hussain, Sidra Shafiq Cheema and Nooman Gilani Tags: Research article Source Type: research